The Kiem Lab studies cell and gene therapy with a particular interest in the biology of blood and marrow stem cells and the development and use of novel gene therapy and genome editing technologies for ex vivo and in vivo applications. The overall goal is to develop better stem cell transplantation and cell and gene therapy treatments for patients with genetic, infectious, and malignant diseases.